Pharmaceutical Industry

The U.S. Chamber of Commerce reports that the global pharmaceutical industry loses $32 billion each year to counterfeiting.  The FDA recently reported that RFID is the most promising technology to “secure the integrity of the supply chain by providing an accurate drug pedigree, documenting the distribution of the drug from the point of manufacture to the final dispenser.”

While RFID is a promising solution, a hole must be addressed – physical security. Track and trace systems only detect the presence of the tag – not the product itself.  As a result, RFID can actually disguise theft and counterfeiting. 

Conventional RFID tags can be moved easily from one item to another without affecting the RFID function. Nothing prevents someone from opening a shipping carton, removing all RFID tags and placing them on counterfeit items. It’s even easier to remove the RFID tags, steal the assets and leave the tags in the empty carton. 

MIKOH’s physical security process knowledge and patented Smart&Secure platform result in solutions that fill the current hole in RFID.  These solutions instill certainty in pharmaceutical authenticity, while also meeting e-pedigree requirements. SecureContainer eliminates the need for item-level tagging by providing a trusted reusable plastic container (RPC) to track and trace pharmaceutical shipments.

MIKOH pharmaceutical solutions offer assistance in drug/vaccine distribution, chain of custody, theft, and counterfeiting, validating the pedigree of multiple items contained in an RTI (returnable transport item), eliminating the need to read and/or tag all individual items.

MIKOH ensures effective drug and vaccine deliveries around the globe. Some require cold chain temperature monitoring, so a combination of Smart&Secure tags, sensors and SmartContainers are employed to ensure successful delivery.
Direct to consumer? MIKOH's use of tags compatible with smart cell phones helps guarantee delivery to the correct recipient as well as helping to ensure the pedigree of the drug for then end consumer.